Aetna’s legal department remains busy. Days after the company settled out of court with a patient who sued for coverage denial in California, it’s in the news in Florida for much the same reason—but with a bigger claimant.

A pilot that aims to study the use of blockchain-enabled data technology to track and verify specialty prescription drugs has been approved by the FDA.

The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) have updated their clinical guidelines for adjuvant and salvage radiotherapy following prostatectomy.

Prostatic artery embolization (PAE) is an effective, minimally invasive treatment option for men with enlarged prostates, according to a new position statement from four interventional radiology societies.

CVS Health, fresh off a $69 billion takeover of health insurance giant Aetna, saw its revenues increase 34.8% to $61.6 billion during the first quarter of 2019, according to a May 1st earnings report. In addition, net income rose 43%, to $1.4 billion, from the previous year.

Shear wave elastography (SWE) may be an effective tool for characterizing suspicious microcalcifications of the breast first detected on mammograms, according to a new study published in the American Journal of Roentgenology.

The Society of Interventional Radiology (SIR) and numerous other societies have endorsed prostatic artery embolization (PEA) as a safe and effective method to treat an enlarged prostate in certain patients.

As bacterial germs continue to mutate and proliferate due to the overuse of antibiotics, an arm of the United Nations is laying out the disturbing numbers in hopes of stirring people to action all around the world.